StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Down 2.8 % NASDAQ:PIRS opened at $0.18 on Friday. The stock’s 50 day moving average price is $0.21 and its two-hundred day […]
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance PIRS stock opened at $0.18 on Friday. The firm has a market cap of $17.89 million, a PE ratio of -0.52 […]
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report report published on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of NASDAQ PIRS opened at $0.19 on Friday. The firm’s 50 day moving average price is $0.21 and […]
StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note issued to investors on Saturday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance PIRS opened at $0.18 on Friday. The stock has a market capitalization of $17.58 million, a price-to-earnings ratio of […]
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Up 3.1 % Shares of PIRS stock opened at $0.17 on Friday. Pieris Pharmaceuticals has a fifty-two week low of $0.14 and […]